Analyst Consensus ?
ConsensusHold52 ratings
Bullish2344.2%
Neutral2853.9%
Bearish11.9%
FN2 Earnings Intelligence
Marriott International, Inc. analyst ratings
Marriott International, Inc. (MAR) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$334.69Current
$160Low
$326.29Average
$449High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Sep 10, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 20, 2026 |
| Macquarie | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 4, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 4, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 4, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 4, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 21, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 21, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 17, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Apr 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 11, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 11, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jan 15, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 16, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 21, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 1, 2024 |
| Credit Suisse | Hold | Hold | Maintain | Feb 16, 2023 |
| Redburn Partners | Sell | Sell | Maintain | Nov 30, 2022 |
| Berenberg | Buy | Hold | Upgrade | Sep 15, 2022 |
| Loop Capital | Hold | Hold | Maintain | Feb 16, 2022 |
| Gordon Haskett | Hold | Hold | Maintain | Jun 26, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | Jun 23, 2020 |
| Nomura | Buy | Buy | Maintain | Jun 23, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 13, 2020 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Mar 30, 2020 |
| CFRA | Hold | Hold | Maintain | Feb 28, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 27, 2020 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 7, 2020 |
| Longbow Research | Neutral | Underperform | Upgrade | Jul 15, 2019 |
| Argus | Hold | Buy | Downgrade | Nov 20, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 23, 2018 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 30, 2017 |
| Guggenheim | Neutral | Neutral | Maintain | Apr 26, 2017 |
| MKM Partners | Buy | Neutral | Upgrade | Dec 5, 2016 |
| Canaccord Genuity | Buy | Buy | Maintain | Mar 23, 2016 |
| Telsey Advisory Group | Perform | Market Perform | Maintain | Jan 4, 2016 |
| Brean Capital | Hold | Hold | Maintain | Jun 25, 2015 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 19, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Sep 9, 2014 |
| Bank of America | Buy | Buy | Maintain | Jan 13, 2014 |
| Oddo Securities | Neutral | Reduce | Upgrade | Jul 2, 2013 |
| ISI Group | Buy | Neutral | Upgrade | Jun 3, 2013 |
| Evercore Partners | Overweight | Overweight | Maintain | May 29, 2013 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Jan 14, 2013 |
| McNicoll Lewis Vlak | Hold | Hold | Maintain | Oct 5, 2012 |
| Keefe, Bruyette & Woods | Market Perform | Outperform | Downgrade | Sep 26, 2012 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Sep 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $334.69. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $360 | $332.84 | +7.6% | Sep 10, 2026 |
| UBS | Robin Farley | $395 | $359.95 | +18.0% | Aug 20, 2026 |
| Deutsche Bank | Analyst unavailable | $372 | $344.7 | +11.1% | Aug 4, 2026 |
| Robert W. Baird | Analyst unavailable | $393 | $346.83 | +17.4% | Aug 4, 2026 |
| Barclays | Brandt Montour | $348 | $346.83 | +4.0% | Aug 4, 2026 |
| BMO Capital | Analyst unavailable | $395 | $346.83 | +18.0% | Aug 3, 2026 |
| Stifel Nicolaus | Simon Yarmak | $343 | $345.78 | +2.5% | Aug 3, 2026 |
| Barclays | Analyst unavailable | $379 | $366.24 | +13.2% | Jul 20, 2026 |
| Wells Fargo | Analyst unavailable | $449 | $369.05 | +34.2% | Jul 16, 2026 |
| Bernstein | Analyst unavailable | $412 | $402.79 | +23.1% | Jun 15, 2026 |
| UBS | Analyst unavailable | $412 | $402.54 | +23.1% | Jun 15, 2026 |
| Bernstein | Analyst unavailable | $402 | $353.47 | +20.1% | May 15, 2026 |
| Morgan Stanley | Analyst unavailable | $353 | $354.77 | +5.5% | May 12, 2026 |
| Wells Fargo | Analyst unavailable | $446 | $355.54 | +33.3% | May 7, 2026 |
| Argus Research | John Staszak | $425 | $354.67 | +27.0% | May 7, 2026 |
| Deutsche Bank | Steven Pizzella | $376 | $354.87 | +12.3% | May 7, 2026 |
| Mizuho Securities | Analyst unavailable | $384 | $359.06 | +14.7% | May 7, 2026 |
| Robert W. Baird | Analyst unavailable | $386 | $359.06 | +15.3% | May 7, 2026 |
| Barclays | Analyst unavailable | $376 | $359.06 | +12.3% | May 7, 2026 |
| Evercore ISI | Analyst unavailable | $400 | $367.08 | +19.5% | Apr 24, 2026 |
| Susquehanna | Christopher Stathoulopoulos | $385 | $367.13 | +15.0% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $372 | $363.74 | +11.1% | Apr 16, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $354.2 | +4.6% | Apr 10, 2026 |
| Truist Financial | Patrick Scholes | $350 | $366.67 | +4.6% | Feb 11, 2026 |
| Evercore ISI | Analyst unavailable | $385 | $366.5 | +15.0% | Feb 11, 2026 |
| Mizuho Securities | Ben Chaiken | $343 | $359.35 | +2.5% | Feb 11, 2026 |
| Goldman Sachs | Lizzie Dove | $398 | $358.15 | +18.9% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $358 | $359.35 | +7.0% | Feb 11, 2026 |
| BMO Capital | Analyst unavailable | $400 | $359.35 | +19.5% | Feb 10, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $320.56 | +4.6% | Jan 22, 2026 |
| Morgan Stanley | Stephen Grambling | $328 | $325.79 | -2.0% | Jan 16, 2026 |
| Barclays | Brandt Montour | $320 | $325.79 | -4.4% | Jan 16, 2026 |
| BMO Capital | Analyst unavailable | $370 | $324.91 | +10.6% | Jan 9, 2026 |
| Bernstein | Analyst unavailable | $369 | $314.95 | +10.3% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $276 | $305.97 | -17.5% | Dec 17, 2025 |
| Goldman Sachs | Lizzie Dove | $345 | $298.78 | +3.1% | Dec 15, 2025 |
| Truist Financial | Patrick Scholes | $283 | $306.65 | -15.4% | Dec 4, 2025 |
| Goldman Sachs | Analyst unavailable | $288 | $281.86 | -14.0% | Nov 5, 2025 |
| Barclays | Brandt Montour | $274 | $272.24 | -18.1% | Nov 5, 2025 |
| Morgan Stanley | Stephen Grambling | $296 | $268.43 | -11.6% | Oct 22, 2025 |
| Barclays | Brandt Montour | $262 | $266.4 | -21.7% | Oct 3, 2025 |
| Argus Research | Analyst unavailable | $310 | $261.8 | -7.4% | Sep 18, 2025 |
| Bernstein | Analyst unavailable | $327 | $262.05 | -2.3% | Sep 17, 2025 |
| Truist Financial | Patrick Scholes | $278 | $265.07 | -16.9% | Sep 3, 2025 |
| Susquehanna | Christopher Stathoulopoulos | $280 | $273.23 | -16.3% | May 16, 2025 |
| Morgan Stanley | Analyst unavailable | $298 | $270.8 | -11.0% | Mar 4, 2025 |
| Evercore ISI | Duane Pfennigwerth | $330 | $290.75 | -1.4% | Feb 4, 2025 |
| Wells Fargo | Daniel Politzer | $285 | $290.75 | -14.8% | Feb 4, 2025 |
| Robert W. Baird | Michael Bellisario | $285 | $290.46 | -14.8% | Feb 3, 2025 |
| BMO Capital | Ari Klein | $265 | $259.66 | -20.8% | Nov 5, 2024 |
| Robert W. Baird | Michael Bellisario | $264 | $259.53 | -21.1% | Nov 5, 2024 |
| Mizuho Securities | Ben Chaiken | $246 | $259.66 | -26.5% | Nov 5, 2024 |
| Goldman Sachs | Lizzie Dove | $280 | $259.66 | -16.3% | Nov 5, 2024 |
| BMO Capital | Ari Klein | $255 | $264.97 | -23.8% | Oct 22, 2024 |
| Robert W. Baird | Michael Bellisario | $258 | $262.57 | -22.9% | Oct 17, 2024 |
| Bank of America Securities | Shaun Kelley | $275 | $253.04 | -17.8% | Sep 27, 2024 |
| Goldman Sachs | Lizzie Dove | $267 | $235.61 | -20.2% | Sep 18, 2024 |
| Bernstein | Richard Clarke | $262 | $231.37 | -21.7% | Aug 29, 2024 |
| Wells Fargo | Daniel Politzer | $238 | $216.12 | -28.9% | Aug 1, 2024 |
| Barclays | Brandt Montour | $240 | $227.3 | -28.3% | Aug 1, 2024 |
| Mizuho Securities | Ben Chaiken | $260 | $237.41 | -22.3% | Apr 23, 2024 |
| Mizuho Securities | Ben Chaiken | $263 | $252.11 | -21.4% | Mar 25, 2024 |
| Morgan Stanley | Stephen W Grambling | $225 | $191.62 | -32.8% | Sep 26, 2023 |
| Jefferies | Analyst unavailable | $184 | $174.96 | -45.0% | Feb 3, 2023 |
| Truist Financial | Analyst unavailable | $205 | $161.44 | -38.7% | Nov 15, 2022 |
| Barclays | Brandt Montour | $170 | $164.07 | -49.2% | Aug 15, 2022 |
| Argus Research | John Staszak | $203 | $154.02 | -39.3% | May 19, 2022 |
| BMO Capital | Ari Klein | $183 | $178.19 | -45.3% | May 5, 2022 |
| Stifel Nicolaus | Simon Yarmak | $180 | $179.38 | -46.2% | May 4, 2022 |
| Morgan Stanley | Analyst unavailable | $182 | $176.28 | -45.6% | May 2, 2022 |
| Truist Financial | Patrick Scholes | $182 | $174.92 | -45.6% | Feb 20, 2022 |
| Morgan Stanley | Thomas Allen | $172 | $183.26 | -48.6% | Feb 16, 2022 |
| Wells Fargo | Dori Kesten | $199 | $181.2 | -40.5% | Feb 15, 2022 |
| Cowen & Co. | Kevin Kopelman | $180 | $156.53 | -46.2% | Dec 7, 2021 |
| Evercore ISI | Steve Sakwa | $160 | $155.02 | -52.2% | Oct 19, 2021 |
Track every rating change on MAR the moment it posts. Free to start.
Start free